The UC Berkeley Center for the Science of Psychedelics, Psychedelic Alpha, and Calyx Law have collaborated on an interactive law and policy map to monitor the rapidly evolving landscape of psychedelic legislation across the United States. This visual tool aims to provide real-time updates on state-level bills and initiatives focused on decriminalization and legal access to psychedelic therapies.
As the field of psychedelic research gains momentum, an increasing number of states are considering reforms to existing drug policies. The law and policy map will offer researchers, policymakers, and the public a clear, at-a-glance view of where changes occur and what specific measures are being proposed or enacted.
Through the map, visitors can view a state’s milestone legislation or attempted legislation, explore local reforms, and track initiatives in cities across the U.S. The key also enables visitors to filter by type, including decriminalization and judicial exception, and to compare failed and active legislation.
The BCSP maintains this map in collaboration with Psychedelic Alpha and Calyx Law. Psychedelic Alpha is an independent media outlet, community, and consultancy firm that strives to empower a diverse constellation of individuals and organizations with the knowledge, network, and nuance to make an impact within the field of psychedelic medicine and beyond. Calyx Law is a boutique law firm focusing on psychedelics and emerging technologies.
Calyx Law
Calyx Law, established in 2016, is a boutique law firm specializing in psychedelics and emerging technologies. While a flower is budding, it is protected by a whorl of sepals that enclose the flower as it emerges and provide stability as it opens. This structure is the calyx. Like a calyx, Calyx Law sees its role as providing seed-stage and early-stage companies with the protection and support they need to come into full bloom, primarily through the strategic use of patents and other intellectual property to generate value and spur growth.
Psychedelic Alpha
Psychedelic Alpha is an independent media outlet, community, and consultancy firm that strives to empower a diverse constellation of individuals and organizations with the knowledge, network, and nuance to make an impact within the field of psychedelic medicine and beyond.
Through its trusted resources, timely analyses, and contributions from subject matter experts it seeks to cut through the noise and explore how we might address the clinical, cultural, and cost-based barriers to the potential roll-out of psychedelic therapies.